Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD

Journal of Clinical Investigation

Volumn 98, Issue 10, 1996, Pages 2209-2217

  Murry, Charles E ^a   Kay, Mark A ^a,b   Bartosek, Trudy ^a   Hauschka, Stephen D ^b   Schwartz, Stephen M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

myocardial infarct repair; myocardial infarction; MyoD; myogenic determination factor; regeneration

Indexed keywords

MYOD PROTEIN; MYOGENIN; MYOSIN HEAVY CHAIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE TRANSFER; GRANULATION TISSUE; HEART MUSCLE NECROSIS; MALE; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR FORMATION; SKELETAL MUSCLE;

EID: 0029834848     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119030     Document Type: Article

References (57)

1. Mallory, G.K., P.D. White, and J. Salcedo-Salgar. 1939. The speed of healing of myocardial infarction: a study of the pathologic anatomy in 72 cases. Am. Heart J. 18:647-671.
2. Quaini, F., E. Cigola, C. Lagrasta, G. Saccani, E. Quaini, C. Rossi, G. Olivetti, and P. Anversa. 1994. End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ. Res. 75:1050-1063.
3. Davis, R.L., H. Weintraub, and A.B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 51:987-1000.
4. Weintraub, H., R. Davis, S. Tapscott, M. Thayer, M. Krause, R. Benezra, T.K. Blackwell, D. Turner, R. Rupp, S. Hollenberg, et al. 1991. The MyoD gene family: nodal point during specification of the muscle cell lineage. Science (Wash. DC). 251:761-766.
5. Tam, S.K.C., W. Gu, and B. Nadal-Ginard. 1995. Molecular cardiomyoplasty: potential cardiac gene therapy for chronic heart failure. J. Thorac. Cardiovasc. Surg. 109:918-924.
6. Olson, E.N., and W.H. Klein. 1994. bHLH factors in muscle developmeat: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8:1-8.
7. Tapscott, S.J., and H. Weintraub. 1991. MyoD and the regulation of myogenesis by helix-loop-helix proteins. J. Clin. Invest. 87:1133-1138.
8. Rudnicki, M.A., P.N.J. Schnegelsberg, R.H. Stead, T. Braun, H. Arnold, and R. Jaenisch. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell. 75:1351-1359.
9. Hasty, P., A. Bradley, J.H. Morris, D.G. Edmondson, J.M. Venuti, E.N. Olson, and W.H. Klein. 1993. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature (Lond.). 364:501-506.
10. Nabeshima, Y., K. Hanaoka, M. Hayasaka, E. Esumi, S. Li, and I. Nonaka. 1993. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature (Lond.). 364:532-535.
11. Thayer, M.J., S.J. Tapscott, R.L. Davis, W.E. Wright, A.B. Lassar, and H. Weintraub. 1989. Positive autoregulation of the myogenic determination gene MyoD1. Cell. 58:241-248.
12. Graham, F.L., and L. Prevec. 1991. Manipulation of adenovirus vectors. In Methods in Molecular Biology. Vol. 7: Gene Transfer and Expression Protocols. E.J. Murray, editor. Humana Press Inc., Clifton, NJ. 109-128.
13. Fang, B., R.C. Eisensmith, X.H.C. Li, M.J. Finegold, A. Shedlovsky, W. Dove, and S.C.C. Woo. 1994. Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Ther. 1:247-254.
14. McGrory, W.J., D.S. Bautista, and F.L. Graham. 1988. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology. 163:614-617.
15. Stratford-Perricaudet, L.D., I. Makeh, M. Perricaudet, and P. Briand. 1992. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90:626-630.
16. Vracko, R., D. Thorning, R.G. Frederickson, and D. Cunningham. 1988. Myocyte reactions at the borders of injured and healing rat myocardium. Lab. Invest. 59:104-114.
17. Murry, C.E., C.M. Giachelli, S.M. Schwartz, and R. Vracko. 1994. Macrophages express osteopontin during repair of myocardial necrosis. Am. J. Pathol. 145:1450-1462.
18. Vracko, R., and D. Thorning. 1991. Contractile cells in rat myocardial scar tissue. Lab. Invest. 65:214-227.
19. Vracko, R., D. Thorning, and RG. Frederickson. 1990. Fate of nerve fibers in necrotic, healing and healed rat myocardium. Lab. Invest. 63:490-501.
20. Villarreal, F.J., N.N. Kim, G.D. Ungab, M.P. Printz, and W.H. Dillmann. 1993. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation. 88:2849-2861.
21. Bader, D., T. Masaki, and D.A. Fischman. 1982. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95:763-770.
22. Havenith, M.G., R. Visser, J.M.C. Schrijvers-van Schendel, and F.T. Bosman. 1990. Muscle fiber typing in routinely processed skeletal muscle with monoclonal antibodies. Histochemistry. 93:497-499.
23. Rudnicki, M.A., G. Jackowski, L. Saggin, and M.W. McBurney. 1990. Actin and myosin expression during development of cardiac muscle from cultured embryonal carcinoma cells. Dev. Biol. 138:348-358.
24. Schiaffino, S., L. Gorza, G. Pitton, L. Saggin, S. Ausoni, S. Sartore, and T. Lomo. 1988. Embryonic and neonatal myosin heavy chain in denervated and paralyzed rat skeletal muscle. Dev. Biol. 127:1-11.
25. Schiaffino, S., L. Gorza, S. Sartore, L. Saggin, and M. Carli. 1986. Embryonic myosin heavy chain as a differentiation marker of developing human skeletal muscle and rhabdomyosarcoma. A monoclonal antibody study. Exp. Cell Res. 163:211-220.
26. Tallini, B., D.M. Parham, P. Dias, C. Cordon-Cardo, P.J. Houghton, and J. Rosai. 1994. Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation. Am. J. Pathol. 144:693-701.
27. Wright, W.E., M. Binder, and W. Funk. 1991. Cyclic amplification and target selection (casting) for the myogenin binding site. Mol. Cell. Biol. 11: 4104-4111.
28. Lee, S.W., B.C. Trapnell, J.J. Rade, R. Virmani, and D.A. Dichek. 1993. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotic arteries. Circ. Res. 73:797-807.
29. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
30. Kass-Eisler, A., E. Falck-Pedersen, M. Alvira, J. Rivera, P.M. Buttrick, B.A. Wittenberg, L. Cipriani, and L.A. Leinwand. 1993. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 90:11498-11502.
31. Olson, E.N. 1992. Interplay between proliferation and differentiation within the myogenic lineage. Dev. Biol. 154:261-272.
32. Templeton, T.J., and S.D. Hauschka. 1992. FGF-mediated aspects of skeletal muscle growth and differentiation are controlled by a high affinity receptor. Dev. Biol. 154:169-181.
33. Clegg, C.H., T.A. Linkhart, B.A. Olwin, and S.D. Hauschka. 1987. Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J. Cell Biol. 105:949-956.
34. Magrin, K.A., D.Z. Ewton, and J.R. Florini. 1991. The role of the IGFs in myogenic differentiation. In Molecular Biology and Physiology of Insulin and Insulin-Like Growth Factors. M.K. Raizada and D. LeRoith, editors. Plenum Press, New York. 57-76.
35. Ontell, M.P., D. Hughes, S.D. Hauschka, and M. Ontell. 1992. Transient neonatal denervation alters the proliferative capacity of myosatellite cells in dystrophic (129ReJdy/dy) muscle. J. Neurobiol. 23:407-419.
36. Prentice, H., R.A. Kloner, V. Sartorelli, S.D. Bellows, K. Alker, and L. Kedes. 1993. Transformation of cardiac fibroblasts into the skeletal muscle phenotype by injection of a MyoD-expressing retrovirus into ischemic heart. Circulation. 88(Suppl.):I475a. (Abstr.)
37. Faerman, A., S. Pearson-White, C. Emerson, and M. Shani. 1993. Ectopic expression of MyoD1 in mice causes prenatal lethalities. Dev. Dynam. 196:165-173.
38. Miner, J.H., J.B. Miller, and B.J. Wold. 1992. Skeletal muscle phenotypes initiated by ectopic MyoD in transgenic mouse heart. Development (Cambridge). 114:853-860.
39. Santerre, R., K. Bales, M. Janney, K. Hannon, L. Fisher, C. Bailey, J. Morris, R. Ivarie, and C. Smith. 1993. Expression of bovine myf5 induces ectopic skeletal muscle formation in transgenic mice. Mol. Cell. Biol. 13:6044-6051.
40. Edwards, J.G., G.E. Lyons, B.K. Micales, A. Malhotra, S. Factor, and L.A. Leinwand. 1996. Cardiomyopathy in transgenic myf5 mice. Circ. Res. 78: 379-387.
41. Hopwood, N.D., and J.B. Gurdon. 1990. Activation of muscle genes without myogenesis by ectopic expression of MyoD in frog embryo cells. Nature (Lond.). 347:197-200.
42. Ludolph, D.C., A.W. Neff, A.L. Mescher, G.M. Malacinski, M.A. Parker, and R.C. Smith. 1994. Overexpression of XMyoD or XMyf5 in Xenopus embryos induces the formation of enlarged myotomes through recruitment of cells of nonsomitic lineage. Dev. Biol. 166:18-33.
43. Weintraub, H., S.J. Tapscott, R.L. Davis, M.J. Thayer, M.A. Adam, A.B. Lassar, and A.D. Miller. 1989. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. USA. 86:5434-5438.
44. Choi, J., M.L. Costa, C.S. Mermelstein, C. Chagas, S. Holtzer, and H. Holtzer. 1990. MyoD converts primary dermal fibroblasts, chondroblasts. smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc. Natl. Acad. Sci. USA. 87: 7988-7992.
45. Schafer, B.W., B.T. Blakey, G.J. Darlington, and H.M. Blau. 1990. Effect of cell history on response to helix-loop-helix family of myogenic regulators. Nature (Lond.). 344:454-458.
46. Bengal, E., L. Ransone, R. Scharfmann, V.J. Dwarki, S.J. Tapscott, H. Weintraub, and I.M. Verma. 1992. Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell. 68:507-519.
47. Li, L., J.-C. Chambard, M. Karin, and E.N. Olson. 1992. Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression. Genes Dev. 6:676-689.
48. Skapek, S.X., J. Rhee, D.B. Spicer, and A.B. Lassar. 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science (Wash. DC). 267:1022-1024.
49. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Wash. DC). 267: 1018-1021.
50. Kaushal, S., J.W. Schneider, B. Nadal-Ginard, and V. Mahdavi. 1994. Activation of the myogenic lineage by MEF2A, a factor that induces and cooperates with MyoD. Science (Wash. DC). 266:1236-1240.
51. Molkentin, J.D., B.L. Black, J.F. Martin, and E.N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell. 83:1125-1136.
52. Yang, Y., F.A. Nunes, K. Berencsi, E.E. Furth, E. Gonczol, and J.M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA. 91:4407-4411.
53. Kay, M.A., A.-X. Holterman, L. Meuse, A.M. Gown, H.D. Ochs, P.S. Linsley, and C.B. Wilson. 1995. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat. Genet. 11:191-197.
54. Koh, G.Y., M.G. Klug, M.H. Soonpaa, and L.J. Field. 1993. Differentiation and long-term survival of C2C12 myoblast grafts in heart. J. Clin. Invest. 92:1548-1554.
55. Balogh, S., C.C.G. Naus, and P.A. Merrifield. 1993. Expression of gap junctions in cultured rat L6 cells during myogenesis. Dev. Biol. 155:351-360.
56. MacCalman, C.D., N. Bardeesy, P.C. Holland, and O.W. Blaschuk. 1992. Noncoordinate developmental regulation of N-cadherin, N-CAM, integrin, and fibronectin mRNA levels during myoblast terminal differentiation. Dev. Dynam. 195:127-132.
57. Guyton, A.C. 1991. Textbook of Medical Physiology. W.B. Saunders Co., Philadelphia. 51-110.